[{"id":"1439e0db-e271-4737-9775-b56261959408","acronym":"SNK_ASTER","url":"https://clinicaltrials.gov/study/NCT04872634","created_at":"2021-05-04T11:52:45.506Z","updated_at":"2024-07-02T16:36:27.603Z","phase":"Phase 1/2","brief_title":"A Study to Evaluate the Safety and Anti-tumor Activity of SNK01 (NK Cells) Administered in Combination With Chemotherapy or Chemotherapy / Cetuximab in Local Advanced or Metastatic Non-small Cell Lung Cancer Patients Who Failed Tyrosine Kinase Inhibitor Treatment","source_id_and_acronym":"NCT04872634 - SNK_ASTER","lead_sponsor":"NKMAX Co., Ltd.","biomarkers":" EGFR • ALK • ROS1","pipe":" | ","alterations":" EGFR mutation • ALK mutation • ROS1 mutation","tags":["EGFR • ALK • ROS1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e EGFR mutation • ALK mutation • ROS1 mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Erbitux (cetuximab) • carboplatin • gemcitabine • troculeucel (SNK01)"],"overall_status":"Recruiting","enrollment":" Enrollment 24","initiation":"Initiation: 07/08/2021","start_date":" 07/08/2021","primary_txt":" Primary completion: 05/26/2023","primary_completion_date":" 05/26/2023","study_txt":" Completion: 05/26/2023","study_completion_date":" 05/26/2023","last_update_posted":"2021-07-21"},{"id":"7b85eb3b-3875-4089-a4ec-be34e9cec504","acronym":"","url":"https://clinicaltrials.gov/study/NCT04464967","created_at":"2021-01-18T21:27:41.651Z","updated_at":"2024-07-02T16:36:30.427Z","phase":"Phase 1/2","brief_title":"Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers","source_id_and_acronym":"NCT04464967","lead_sponsor":"NKGen Biotech, Inc.","biomarkers":" EGFR • HER-2","pipe":" | ","alterations":" EGFR positive","tags":["EGFR • HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e EGFR positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Herceptin (trastuzumab) • Erbitux (cetuximab) • troculeucel (SNK01)"],"overall_status":"Withdrawn","enrollment":"","initiation":"Initiation: 03/01/2021","start_date":" 03/01/2021","primary_txt":" Primary completion: 08/01/2022","primary_completion_date":" 08/01/2022","study_txt":" Completion: 02/01/2023","study_completion_date":" 02/01/2023","last_update_posted":"2021-05-12"}]